Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain

ClinicalTrials.gov ID: NCT05096494

Public ClinicalTrials.gov record NCT05096494. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:14 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Placebo-controlled, Parallel Group, Multicenter Study to Evaluate the Safety and Efficacy of SP-103 in Subjects With Moderate to Severe Acute Lower Back Pain

Study identification

NCT ID
NCT05096494
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Scilex Pharmaceuticals, Inc.
Industry
Enrollment
76 participants

Conditions and interventions

Interventions

  • SP-103 Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 75 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 28, 2022
Primary completion
May 29, 2023
Completion
May 29, 2023
Last update posted
Jul 5, 2026

2022 – 2023

United States locations

U.S. sites
10
U.S. states
9
U.S. cities
10
Facility City State ZIP Site status
Arizona Research Center Phoenix Arizona 85053
Costal Clinical Research Specialists Fernandina Beach Florida 32034
Costal Clinical Research Specialists Jacksonville Florida 32250
Horizon Clinical Research Newnan Georgia 30265
Injury Care Research Boise Idaho 83704
Chicago Anesthesia Research Specialists Chicago Illinois 60657
Neuroscience Research Center Overland Park Kansas 66210
Neuroscience Institute, Overlook Medical Center Summit New Jersey 07901
Western Reserve Hospital Cuyahoga Falls Ohio 44223
Scilex Research Site 08 Charleston South Carolina 29406

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05096494, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 5, 2026 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05096494 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →